TY - JOUR
T1 - A cognitive model-based approach to testing mechanistic explanations for neuropsychological decrements during tobacco abstinence
AU - Weigard, Alexander
AU - Huang-Pollock, Cynthia
AU - Heathcote, Andrew
AU - Hawk, Larry
AU - Schlienz, Nicolas J.
N1 - Funding Information:
Acknowledgements Andrew Heathcote would like to acknowledge the Australian Research Council grant DP160101891 for supporting his work on this project.
Publisher Copyright:
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Rationale: Cigarette smokers often experience cognitive decrements during abstinence from tobacco, and these decrements may have clinical relevance in the context of smoking cessation interventions. However, limitations of the behavioral summary statistics used to measure cognitive effects of abstinence, response times (RT) and accuracy rates, may restrict the field’s ability to identify robust abstinence effects on task performance and test mechanistic hypotheses about the etiology of these cognitive changes. Objectives: The current study explored whether a measurement approach based on mathematical models of cognition, which make the cognitive mechanisms necessary to perform choice RT tasks explicit, would be able to address these limitations. Methods: The linear ballistic accumulator model (LBA: Brown and Heathcote, Cogn Psychol 57(3):153-178, 2008) was fit to an existing data set from a study that evaluated the impact of overnight abstinence on flanker task performance. Results: The model-based analysis provided evidence that smokers’ rates of mind wandering increased during abstinence, and was able to index this effect while controlling for participants’ strategy changes that were related to the specific experimental paradigm used. Conclusion: Mind wandering is a putative explanation for cognitive withdrawal symptoms during smoking cessation and may be indexed using the LBA. More broadly, the use of formal model-based analyses in future research on this topic has the potential to allow for strong and specific tests of mechanistic explanations for these symptoms.
AB - Rationale: Cigarette smokers often experience cognitive decrements during abstinence from tobacco, and these decrements may have clinical relevance in the context of smoking cessation interventions. However, limitations of the behavioral summary statistics used to measure cognitive effects of abstinence, response times (RT) and accuracy rates, may restrict the field’s ability to identify robust abstinence effects on task performance and test mechanistic hypotheses about the etiology of these cognitive changes. Objectives: The current study explored whether a measurement approach based on mathematical models of cognition, which make the cognitive mechanisms necessary to perform choice RT tasks explicit, would be able to address these limitations. Methods: The linear ballistic accumulator model (LBA: Brown and Heathcote, Cogn Psychol 57(3):153-178, 2008) was fit to an existing data set from a study that evaluated the impact of overnight abstinence on flanker task performance. Results: The model-based analysis provided evidence that smokers’ rates of mind wandering increased during abstinence, and was able to index this effect while controlling for participants’ strategy changes that were related to the specific experimental paradigm used. Conclusion: Mind wandering is a putative explanation for cognitive withdrawal symptoms during smoking cessation and may be indexed using the LBA. More broadly, the use of formal model-based analyses in future research on this topic has the potential to allow for strong and specific tests of mechanistic explanations for these symptoms.
UR - http://www.scopus.com/inward/record.url?scp=85053371888&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053371888&partnerID=8YFLogxK
U2 - 10.1007/s00213-018-5008-3
DO - 10.1007/s00213-018-5008-3
M3 - Article
C2 - 30182252
AN - SCOPUS:85053371888
SN - 0033-3158
VL - 235
SP - 3115
EP - 3124
JO - Psychopharmacology
JF - Psychopharmacology
IS - 11
ER -